Lyndra Therapeutics reported positive results from a pharmacokinetics study of its once-weekly drug-delivery capsule, touting that it successfully transitioned a once-daily therapy to a weekly dosage form.
The Watertown, Mass.-based company’s oral drug-delivery technique is designed to provide sustained release of one or more drugs for up to a week. Lyndra’s star-shaped capsule opens when it reaches the stomach and eventually leaves the body via the user’s gastrointestinal tract.
Get the full story at our sister site, Drug Delivery Business News.
The post Lyndra touts positive results for long-acting drug-delivery tech appeared first on MassDevice.
from MassDevice https://ift.tt/2FoUNjn
Cap comentari:
Publica un comentari a l'entrada